587 related articles for article (PubMed ID: 12446975)
41. Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond.
Leuchtenberger S; Beher D; Weggen S
Curr Pharm Des; 2006; 12(33):4337-55. PubMed ID: 17105431
[TBL] [Abstract][Full Text] [Related]
42. NSAIDs for the chemoprevention of Alzheimer's disease.
Szekely CA; Town T; Zandi PP
Subcell Biochem; 2007; 42():229-48. PubMed ID: 17612054
[TBL] [Abstract][Full Text] [Related]
43. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
44. [Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
Shen JN; Xu LX; Wang R
Yao Xue Xue Bao; 2013 Dec; 48(12):1743-54. PubMed ID: 24689230
[TBL] [Abstract][Full Text] [Related]
45. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
Ferrera P; Arias C
Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
[TBL] [Abstract][Full Text] [Related]
46. Cyclooxygenase inhibitors: a novel direction for Alzheimer's management.
Nivsarkar M; Banerjee A; Padh H
Pharmacol Rep; 2008; 60(5):692-8. PubMed ID: 19066416
[TBL] [Abstract][Full Text] [Related]
47. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
48. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
McGeer PL; Rogers J; McGeer EG
J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
[TBL] [Abstract][Full Text] [Related]
49. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?
Weggen S; Rogers M; Eriksen J
Trends Pharmacol Sci; 2007 Oct; 28(10):536-43. PubMed ID: 17900710
[TBL] [Abstract][Full Text] [Related]
50. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
51. 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease.
Agdeppa ED; Kepe V; Liu J; Small GW; Huang SC; Petric A; Satyamurthy N; Barrio JR
Mol Imaging Biol; 2003; 5(6):404-17. PubMed ID: 14667495
[TBL] [Abstract][Full Text] [Related]
52. Ibuprofen for Alzheimer's disease.
Tabet N; Feldmand H
Cochrane Database Syst Rev; 2003; (2):CD004031. PubMed ID: 12804498
[TBL] [Abstract][Full Text] [Related]
53. Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures.
Gasparini L; Rusconi L; Xu H; del Soldato P; Ongini E
J Neurochem; 2004 Jan; 88(2):337-48. PubMed ID: 14690522
[TBL] [Abstract][Full Text] [Related]
54. Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?
Trepanier CH; Milgram NW
J Alzheimers Dis; 2010; 21(4):1089-99. PubMed ID: 21504126
[TBL] [Abstract][Full Text] [Related]
55. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
Cryer B; Feldman M
Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023
[TBL] [Abstract][Full Text] [Related]
56. Non-steroidal anti-inflammatory drugs protect amyloid beta protein-induced increase in the intracellular Cl- concentration in cultured rat hippocampal neurons.
Iwata R; Kitagawa K; Zhang NY; Wu B; Inagaki C
Neurosci Lett; 2004 Sep; 367(2):156-9. PubMed ID: 15331142
[TBL] [Abstract][Full Text] [Related]
57. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Gasparini L; Ongini E; Wilcock D; Morgan D
Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
[TBL] [Abstract][Full Text] [Related]
58. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology.
Xiang Z; Ho L; Valdellon J; Borchelt D; Kelley K; Spielman L; Aisen PS; Pasinetti GM
Neurobiol Aging; 2002; 23(3):327-34. PubMed ID: 11959394
[TBL] [Abstract][Full Text] [Related]
59. Ibuprofen: effect on inducible nitric oxide synthase.
Stratman NC; Carter DB; Sethy VH
Brain Res Mol Brain Res; 1997 Oct; 50(1-2):107-12. PubMed ID: 9406924
[TBL] [Abstract][Full Text] [Related]
60. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.
Farías GG; Godoy JA; Vázquez MC; Adani R; Meshulam H; Avila J; Amitai G; Inestrosa NC
Neurobiol Dis; 2005 Feb; 18(1):176-83. PubMed ID: 15649708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
